Gland Pharma Ltd.

NSE: GLAND | BSE: 543245

Strong Performer, Getting Expensive

2543.70 115.40 (4.75%)

Near 52W High of ₹2573.50

1.0M

NSE+BSE Volume

NSE 29 Jul, 2026 3:58 PM (IST)

US FDA Approval

Gland Pharma gets US FDA approval for an anaesthesia reversal drug, with US sales of around $1.6 bn See details

Detailed Stock Analysis for Gland Pharma with Real-time Stock Report

Download Sample Report